Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Hypertension

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 52 articles: HTML format

Single Articles

February 2026
1. BENETOS A, Gautier S, Rossignol P
   Reduction of Antihypertensive Treatment in Nursing Home Residents. Reply.
   N Engl J Med. 2026;394:932-933.
   PubMed    
   
   
   
2. FUJI S
   Reduction of Antihypertensive Treatment in Nursing Home Residents.
   N Engl J Med. 2026;394:932.
   PubMed    
   
   
   
3. ZHANG L, Yang L
   Reduction of Antihypertensive Treatment in Nursing Home Residents.
   N Engl J Med. 2026;394:931-932.
   PubMed    
   
   
   
4. HUART J, Jouret F
   Reduction of Antihypertensive Treatment in Nursing Home Residents.
   N Engl J Med. 2026;394:931.
   PubMed    
   
   
   
5. LU Y, Li L
   Reduction of Antihypertensive Treatment in Nursing Home Residents.
   N Engl J Med. 2026;394:930-931.
   PubMed    
   
   
   
6. STRANDBERG TE
   Reduction of Antihypertensive Treatment in Nursing Home Residents.
   N Engl J Med. 2026;394:930.
   PubMed    
   
   
   
7. FADAKAR PK, Pourvaziri A, Feldman AS, Pier DB, et al
   Case 5-2026: An 18-Year-Old Woman with Headache and Hypertension.
   N Engl J Med. 2026;394:700-709.
   PubMed    
   
   
   January 2026
8. KISHORE SP, Kocher R
   The Hypertension Control Paradox - Why Is America Stuck?
   N Engl J Med. 2026;394:417-420.
   PubMed    
   
   
   
9. HORTON JC
   Idiopathic Intracranial Hypertension. Reply.
   N Engl J Med. 2026;394:414-415.
   PubMed    
   
   
   
10. WANG Y, Liang Z, Weng D
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2026;394:414.
    PubMed    
    
    
    
11. XIAO YJ, Sun H
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2026;394:414.
    PubMed    
    
    
    
12. DO LAGO V, Caldas J
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2026;394:414.
    PubMed    
    
    
    
13. FLACK JM, Dwyer JP, Williams B
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. Reply.
    N Engl J Med. 2026;394:305-306.
    PubMed    
    
    
    
14. JHAVERI KD, Hirsch JS, Fishbane S
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:305.
    PubMed    
    
    
    
15. ZHENG Z, Jiang X, Wu B
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:304.
    PubMed    
    
    
    
16. HIGASHI Y
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:304.
    PubMed    
    
    
    
17. PEDREIRA-BOUZAS J, Pousada-Fonseca A
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:303-304.
    PubMed    
    
    
    November 2025
18. GOREY S, Rothberg M, Chang TI
    To Treat or Not to Treat? Watchful Waiting or Oral Antihypertensives for Asymptomatic Inpatient Hypertension.
    N Engl J Med. 2025;393:2051-2053.
    PubMed    
    
    
    
19. PLACIDO R, Baptista B
    Ortner's Syndrome in Pulmonary Hypertension.
    N Engl J Med. 2025;393:e35.
    PubMed    
    
    
    
20. JIMENEZ C, Andreassen M, Durand A, Moog S, et al
    Belzutifan for Advanced Pheochromocytoma or Paraganglioma.
    N Engl J Med. 2025;393:2012-2022.
    PubMed     Abstract available
    
    
    October 2025
21. HORTON JC
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2025;393:1409-1419.
    PubMed    
    
    
    September 2025
22. MCLAUGHLIN VV, Hoeper MM, Badesch DB, Ghofrani HA, et al
    Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
    N Engl J Med. 2025 Sep 30. doi: 10.1056/NEJMoa2508170.
    PubMed     Abstract available
    
    
    
23. SIEDNER MJ, Magula N, Mazibuko L, Sithole N, et al
    Home-Based Care for Hypertension in Rural South Africa.
    N Engl J Med. 2025 Sep 1. doi: 10.1056/NEJMoa2509958.
    PubMed     Abstract available
    
    
    August 2025
24. FLACK JM, Azizi M, Brown JM, Dwyer JP, et al
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2507109.
    PubMed     Abstract available
    
    
    
25. GUZIK TJ, Tomaszewski M
    Aldosterone Synthase Inhibition for Hypertension.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMe2511533.
    PubMed    
    
    
    
26. BENETOS A, Gautier S, Freminet A, Metz A, et al
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2025 Aug 29. doi: 10.1056/NEJMoa2508157.
    PubMed     Abstract available
    
    
    
27. LAFFIN LJ, Rodman D, Nissen SE
    Lorundrostat Efficacy and Safety in Uncontrolled Hypertension. Reply.
    N Engl J Med. 2025;393:726-727.
    PubMed    
    
    
    
28. POLLOCK JM 3RD
    Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.
    N Engl J Med. 2025;393:726.
    PubMed    
    
    
    
29. BURGOS E, Fernandez Fernandez B, Ortiz A
    Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.
    N Engl J Med. 2025;393:725-726.
    PubMed    
    
    
    June 2025
30. GARVEY WT, Bluher M, Osorto Contreras CK, Davies MJ, et al
    Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.
    N Engl J Med. 2025 Jun 22. doi: 10.1056/NEJMoa2502081.
    PubMed     Abstract available
    
    
    May 2025
31. MARON BA
    Sotatercept and the Clinical Transformation of Pulmonary Arterial Hypertension.
    N Engl J Med. 2025;392:2059-2061.
    PubMed    
    
    
    April 2025
32. LAFFIN LJ, Kopjar B, Melgaard C, Wolski K, et al
    Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension.
    N Engl J Med. 2025 Apr 23. doi: 10.1056/NEJMoa2501440.
    PubMed     Abstract available
    
    
    March 2025
33. HUMBERT M, McLaughlin VV, Badesch DB, Ghofrani HA, et al
    Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.
    N Engl J Med. 2025 Mar 31. doi: 10.1056/NEJMoa2415160.
    PubMed     Abstract available
    
    
    
34. MAGNUSSEN C, Alegre-Diaz J, Al-Nasser LA, Amouyel P, et al
    Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.
    N Engl J Med. 2025 Mar 30. doi: 10.1056/NEJMoa2415879.
    PubMed     Abstract available
    
    
    January 2025
35. VAIDYA A, Morlote M, Moussa M, Barletta J, et al
    Targeting a Hormonal Cause of Hypertension.
    N Engl J Med. 2025;392:e14.
    PubMed    
    
    
    November 2024
36. BI Y, Li M, Liu Y, Li T, et al
    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.
    N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2412006.
    PubMed     Abstract available
    
    
    June 2024
37. MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH
    Prevention of Cardiovascular Disease in Type 1 Diabetes. Reply.
    N Engl J Med. 2024;390:2227.
    PubMed    
    
    
    May 2024
38. NAJEM M, Dong E
    Esophageal Varices, White-Nipple Sign, and Portal Hypertensive Gastropathy.
    N Engl J Med. 2024;390:e47.
    PubMed    
    
    
    
39. LI G, Lin Y, Yang J, Anderson CS, et al
    Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke.
    N Engl J Med. 2024 May 16. doi: 10.1056/NEJMoa2314741.
    PubMed     Abstract available
    
    
    
40. EDLOW JA
    Lowering Blood Pressure in Stroke Patients in the Ambulance - A Bridge Too Close?
    N Engl J Med. 2024 May 16. doi: 10.1056/NEJMe2402356.
    PubMed    
    
    
    April 2024
41. KUROLAP A, Chai Gadot C, Baris Feldman H
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis. Reply.
    N Engl J Med. 2024;390:1539-1540.
    PubMed    
    
    
    
42. ABASSI Z, Azzam ZS, Heyman SN
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1539.
    PubMed    
    
    
    
43. GLADYSHEVA IP, Wang D, Reed GL
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1538-1539.
    PubMed    
    
    
    
44. DOMINY J, Koch C, Lamarche L, Denning D, et al
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1537-1538.
    PubMed    
    
    
    
45. CHEN B, Wei M
    Aortic Coarctation.
    N Engl J Med. 2024;390:1420.
    PubMed    
    
    
    
46. VAZQUEZ MA, Oliver G, Amarasingham R, Sundaram V, et al
    Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.
    N Engl J Med. 2024;390:1196-1206.
    PubMed     Abstract available
    
    
    December 2023
47. JAUREGUI R, Busis NA
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2023;389:2467.
    PubMed    
    
    
    November 2023
48. BARIS FELDMAN H, Chai Gadot C, Zahler D, Mory A, et al
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2023;389:1685-1692.
    PubMed     Abstract available
    
    
    October 2023
49. DESAI AS, Sweetser MT, Bakris GL
    Zilebesiran for Hypertension. Reply.
    N Engl J Med. 2023;389:1439-1440.
    PubMed    
    
    
    
50. VAN TWIST DJL, Kalic H
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438-1439.
    PubMed    
    
    
    
51. LIFSCHITZ M
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438.
    PubMed    
    
    
    
52. ABASHEVA D, Fernandez-Fernandez B, Ortiz A
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum